DRNA

COM:DICERNA

Novo Nordisk

  • Stock

Last Close

38.22

01/01 00:00

Volume Today

5.54M

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Pharmaceuticals
  • website

    www.dicerna.com
  • ipo date

    Jan 30, 2014

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-m...Show More

peer of

competitor of